Stacey McGeown/LinkedIn
Feb 23, 2026, 14:45
Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
Stacey McGeown, Co-Founder at EquiPath Analytics and Board Trustee at The Haemophilia Society, shared a post on LinkedIn:
“Today kicked off Rare Disease month at the Rare Disease Awareness Day at QUB!
Incredible turnout from both staff and students. I proudly wore my stripes and it was amazing to see so much enthusiasm, engagement, and genuine interest throughout the day.
It was also a privilege to connect with so many wonderful people from other organisations.
Thank you to everyone who took part, showed support, and helped make the day such a success.
Looking forward and seeing you all in Derry in a few weeks.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial